IRF5 and type 2 diabetes mellitus: Classical monocyte expression of IRF5 is specifically increased by 2.1‐fold in patients admitted to the ICU, whereas intermediate monocyte expression of IRF5 is only increased in T2D patients admitted to the ICU (respectively, 3.3‐ and 1.7‐fold relative to ND and T2D not requiring ICU admission; Fig 3H).